Kathryn Anderson’s Final Study Reveals How WNT Signaling Shapes Cell Identity and May Inform Cancer Metastasis Research
Researchers at Memorial Sloan Kettering Cancer Center have published the final study from the late Dr. Kathryn Anderson, focusing on how WNT signaling influences cell identity. The research, which utilized mouse models, provides new insights into developmental biology and potential pathways for cancer metastasis.
Why it matters
Understanding the mechanisms of WNT signaling is critical for advancing cancer research and developing new therapeutic strategies for metastasis.
More than five years after the death of developmental biologist Kathryn Anderson, PhD, researchers at Memorial Sloan Kettering Cancer Center have completed and published the final study originating from her laboratory.
The paper, titled “AXIN1 and AXIN2 regulate the WNT-signaling landscape to promote distinct mesoderm programs,” represents both a major scientific contribution and the culmination of years of work by Dr. Anderson’s former colleagues and collaborators.
Dr. Anderson joined Memorial Sloan Kettering Cancer Center in 1996 and later served as Chair of the Developmental Biology Program. Her research focused on the fundamental processes that shape early mammalian development, including how highly plastic embryonic cells receive instructions that determine which tissues and organs they will ultimately form.
She died in November 2020 after a career marked by major discoveries in developmental biology.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in